A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
Phase 3
- Conditions
- Metastatic Pancreas Cancer
- Interventions
- First Posted Date
- 2012-04-27
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 175
- Registration Number
- NCT01586611
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer
Phase 1
Withdrawn
- Conditions
- Locally Advanced Cervical CancerIntegrated MRI Based RT as Standard of Care
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT01514955
Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
Phase 1
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Drug: ABT-888/Bortezomib
- First Posted Date
- 2011-12-20
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 19
- Registration Number
- NCT01495351
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
Not Applicable
- Conditions
- High-risk Prostate Cancer
- Interventions
- Radiation: Hypofractionated radiation treatmentRadiation: Standard Radiation Treatment
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 134
- Registration Number
- NCT01488968
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer
- First Posted Date
- 2011-09-20
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT01437254
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant
- Conditions
- Prostate Cancer
- First Posted Date
- 2011-09-20
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 25
- Registration Number
- NCT01437085
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Breast Cancer and Exercise Trial in Alberta
Not Applicable
Completed
- Conditions
- Breast Neoplasms
- Interventions
- Other: High VolumeOther: Moderate Volume
- First Posted Date
- 2011-09-15
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 400
- Registration Number
- NCT01435005
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
π¨π¦Cross Cancer Centre, Edmonton, Alberta, Canada
Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer
Not Applicable
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 8
- Registration Number
- NCT01428739
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer
Phase 1
- Conditions
- Small Cell Lung Cancer
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 10
- Registration Number
- NCT01426841
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2014-10-03
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 20
- Registration Number
- NCT01411072
- Locations
- π¨π¦
Tom Baker Cancer Center, Calgary, Alberta, Canada
π¨π¦Cross Cancer Institute, Edmonton, Alberta, Canada
Β© Copyright 2025. All Rights Reserved by MedPath